Target intelligence / Profile preview

Detrusor smooth muscle of bladder

Molecular classification
Other (tissue/muscle type)
01

Overview

The **detrusor smooth muscle** is the main muscular component of the urinary bladder wall. It is responsible for both storing urine by relaxing during filling and expelling urine by contracting during micturition. The detrusor's function is regulated by complex interactions between nervous system inputs—primarily parasympathetic stimulation for contraction—and hormonal signals. The tissue contains multiple receptor types that mediate these responses, including muscarinic acetylcholine receptors and beta-adrenoceptors[1][4]. Dysfunction or pathological changes in this muscle are implicated in several urological conditions such as overactive bladder syndrome, lower urinary tract symptoms (LUTS), and bladder outlet obstruction[1]. **Note:** "Smooth muscle of bladder" refers to a tissue type rather than a specific molecular target such as a receptor or enzyme. Therefore, it does not fit the definition of a canonical therapeutic target molecule; instead, it is an anatomical/functional structure composed primarily of contractile cells expressing various molecular targets[1][3]. For drug development or mechanistic studies, more precise targets would be individual proteins/receptors within this tissue—such as muscarinic M2/M3 receptors or KV7 potassium channels—rather than the entire smooth muscle itself. If you require structured information on specific molecular targets within the detrusor/bladder smooth muscle (e.g., "Muscarinic acetylcholine receptor M3"), please specify further.

Other names
Bladder smooth muscleUrinary bladder detrusor muscleDetrusor muscle
02

Mechanism of action

Inhibition of muscarinic receptors to reduce involuntary contractions Activation of beta-3 adrenergic receptors to promote relaxation

03

Biological functions

Contraction and relaxation to control urine storage and voiding[1][3][5][7]
04

Disease associations

Lower urinary tract symptoms (LUTS)[1]Bladder outlet obstruction[1]Overactive bladder
05

Safety considerations

Antimuscarinic side effects (dry mouth, constipation, cognitive impairment)
06

Interacting drugs

Antimuscarinics (e.g., oxybutynin, tolterodine)

1 more in the full profile.

Beyond the preview

Go deeper on Detrusor smooth muscle of bladder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Detrusor smooth muscle of bladder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call